CTX-M and ampC β-lactamases contributing to increased prevalence of ceftriaxone-resistant Escherichia coli in Changi General Hospital, Singapore☆☆☆
Received 5 May 2009; accepted 30 August 2009. published online 05 October 2009.
Abstract
Data from an 800-bed hospital showed an increase in the incidence density of ceftriaxone-resistant Escherichia coli, from 13.1 to 21.7 per 100 000 inpatient days over a 4-year period. Detailed testing performed on 54 E. coli isolates showed blaCTX-M extended-spectrum β-lactamase (ESBL) genes (n = 37) and blaCMY-likeampC genes (n = 15). Typing data showed only limited clonal transmission in isolates with ESBL.
☆ Tan Thean Yen, TYT, has received research funding from Wyeth Pharmaceuticals and has been an invited speaker for Wyeth Pharmaceuticals, Astra-Zeneca, and Jansson-Cilag. Hsu Li Yang, HLY, has received research funding from Wyeth Pharmaceuticals.
☆☆ Preliminary data from this study was presented as a poster at the Australian Society of Microbiology, Melbourne, July 6 to 10, 2008.